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Abstract
Objective. Chronic pain is a significant problem in patients living with hepatitis C virus (HCV). Tobacco smoking is an
independent risk factor for high pain intensity among veterans. This study aims to examine the independent associa-
tions with smoking and HCV on pain intensity, as well as the interaction of smoking and HCV on the association with
pain intensity. Design/Particpants. Cross-sectional analysis of a cohort study of veterans of Operations Enduring
Freedom/Iraqi Freedom/New Dawn (OEF/OIF/OND) who had at least one visit to a Veterans Health Administration
(VHA) primary care clinic between 2001 and 2014. Methods. HCV was identified using ICD-9 codes from electronic
medical records (EMRs). Pain intensity, reported on a 0–10 numeric rating scale, was categorized as none/mild (0–3)
and moderate/severe (4–10). Results. Among 654,841 OEF/OIF/OND veterans (median age [interquartile range]¼26
[23–36] years), 2,942 (0.4%) were diagnosed with HCV. Overall, moderate/severe pain intensity was reported in 36%
of veterans, and 37% were current smokers. The adjusted odds of reporting moderate/severe pain intensity were
1.23 times higher (95% confidence interval [CI]¼ 1.14–1.33) for those with HCV and 1.26 times higher (95%
CI¼ 1.25–1.28) for current smokers. In the interaction model, there was a significant Smoking Status  HCV interac-
tion (P ¼ 0.03). Among veterans with HCV, smoking had a significantly larger association with moderate/severe pain
(adjusted odds ratio [OR]¼ 1.50, P < 0.001) than among veterans without HCV (adjusted OR¼ 1.26, P < 0.001).
Conclusions. We found that current smoking is more strongly linked to pain intensity among veterans with HCV.
Further investigations are needed to explore the impact of smoking status on pain and to promote smoking cessa-
tion and pain management in veterans with HCV.
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Introduction
Hepatitis C virus (HCV) is the most common blood-
borne infection in the United States [1] and dispropor-
tionately affects US veterans. Compared with the general
US population, HCV is two to three times more prevalent
among veterans [2]. Within the population of US veter-
ans, HCV is linked to increased likelihood of chronic
pain and diagnosed pain disorders. Specifically among
veterans with HCV who use Veterans Health
Administration (VHA) health care services, up to 67% of
have a documented pain diagnosis [3]. Pain conditions
vary and include musculoskeletal pain, fibromyalgia, ar-
thritis, and peripheral neuropathy [4]. Chronic pain
among those living with HCV has multiple notable harm-
ful effects, including increased incidence of psychiatric
symptoms, decreased quality of life, and health care costs
[5–7]. Although the etiology and mechanisms of pain
among people with HCV are not fully understood, it is
possible that tobacco smoking may play a role. Notably,
there is new evidence linking smoking to joint pain in
patients with HCV [8]. This is a significant issue because
veterans with comorbid HCV and chronic pain are likely
to smoke [5]. Despite the potential connection between
HCV, smoking, and pain, this area is relatively under-
studied among veterans with HCV.
Both pain and smoking are relevant health concerns
for veterans of Operations Enduring Freedom/Iraqi
Freedom/New Dawn (OEF/OIF/OND) [9]. More than
one-third of veterans from this relatively young cohort
report moderate to severe pain intensity [10], and na-
tional data indicate that persons age 20–40 years (the ap-
proximate age range of this veteran cohort) have the
highest incidence rate of acute HCV infection [11].
Smoking may be a particularly salient risk factor for pain
among OEF/OIF/OND veterans. In a recent study of this
cohort, current smokers were more likely to present with
high pain intensity compared with former and never
smokers [10].
A number of factors likely affect pain intensity in the
context of HCV, including liver functioning, HCV phar-
macotherapy, access to and type of pain treatment (e.g.,
opioid medication), and mental health disorders.
Multiple studies of veterans with HCV have indicated
that pain intensity is less associated with biological dis-
ease indicators and more associated with psychological
processes such as depression or pain catastrophizing [12].
Although there is a growing body of research characteriz-
ing the overlap and interconnection between HCV, pain,
and mental health symptoms [5,13], far less attention has
been paid to how smoking and HCV may interact to in-
crease risk for pain.
Smoking is highly prevalent among veterans with
HCV, and moreover, it is likely to be associated with
pain intensity. Among veterans with HCV who use VHA
health care services, tobacco use is the most common
substance use disorder, with 66% reporting a history of
tobacco use [14]. High smoking rates in this group are es-
pecially troubling as cigarette smoking is generally asso-
ciated with higher pain intensity and greater functional
impairment [15,16]. It is generally hypothesized that
while smokers utilize tobacco to cope with or reduce
pain, smoking also increases risk for chronic pain
[15,17].
Given the high rates and clinical importance of HCV,
smoking, and chronic pain among OEF/OIF/OND veter-
ans, we aimed to examine the association of smoking and
HCV with pain intensity. We had two hypotheses: 1)
smoking and HCV would both be independently associ-
ated with pain intensity and 2) the association of smok-
ing and pain intensity would be significantly higher for
veterans with HCV.
Methods
Study Design and Population
The OEF/OIF/OND roster is supplied to the VHA by the
Department of Defense Manpower Data Center’s
(DMDC’s) Contingency Tracking System. The roster
contains all veterans who separated from OEF/OIF/OND
military service and enrolled in VHA health care between
October 1, 2001, and September 30, 2014
(N¼ 1,063,973). Further descriptions of the Women’s
Veterans Cohort can be reviewed by cited manuscript
[18]. Our analyses included veterans who had the follow-
ing: 1) at least one primary care visit at VHA, 2) informa-
tion available on smoking status (N¼ 756,816), and 3)
reported pain intensity proximal to smoking status
(N¼ 654,841). The VHA Connecticut Healthcare
System Institutional Review Boards reviewed and ap-
proved this study.
Data Source
Data on eligible veterans were linked to VHA administra-
tive and clinical data contained within the Corporate
Data Warehouse (CDW). These databases provide a re-
cord of inpatient and outpatient health care encounters
and coded diagnostic conditions (based on the
International Classification of Diseases, Ninth Revision
[ICD-9]).
Measures
Demographic Variables
Variables included sex, education (high school gradua-
tion or equivalent, above high school), race/ethnicity
(black, Hispanic, white, unknown/other), age, service-
connected disability (no service connection to 49%
service connection, 50–100% service connection), and
military characteristics including rank (e.g., officer) and
branch (e.g., US Army).
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Dependent Variable: Pain Intensity
Veterans seen at VHA primary care clinics are asked for
about their pain levels using a 0–10 numeric rating scale
(NRS) [19]. The pain intensity question asks veterans to
“rate your current pain on a 0 (no pain) to 10 (worst
pain imaginable)” range, and the response is recorded in
the veterans’ electronic medical records (EMRs). The
highest current pain intensity score was kept for analysis
(þ/- 30 days of the most recent documentation of smok-
ing status). Similar to previous methodology [19,20], cur-
rent pain intensity was grouped dichotomously into
none/mild (scores ranging from 0 to 3) or moderate/se-
vere (scores ranging from 4 to 10).
Independent Variables of Interest: Cigarette Smoking
Status and HCV Diagnosis
For this study, we identified the most recent smoking sta-
tus. Smoking status was determined using methodology
from McGinnis et al. [21] that uses EMR Health Factors
Smoking data from clinical reminders. Veterans were cat-
egorized as never, former, and current smokers using a
key word algorithm (e.g., current smoker, never smoker,
tobacco counseling). McGinnis found high agreement be-
tween EMR Health Factors smoking data and survey
results [21].
HCV was identified if the veteran ever had any of the
following ICD-9 codes: 070.41, 070.44, 070.51, 070.54,
and V02.62.
Covariates
In multivariate analysis, we selected the following a pri-
ori covariates: sex, age, race/ethnicity, pain-related diag-
nosis, and mental health diagnoses. Using existing
methodology [22], pain-related diagnosis was determined
via diagnostic codes for the following back pain condi-
tions: joint disorders, osteoarthritis, back conditions,
headache, cervicalgia, degeneration of lumbar, lumbosa-
cral, or intervertebral disc, musculoskeletal/connective
tissue disorders, and peripheral neuropathy. To identify
these disorders, we used the following ICD-9 codes:
307.81, 307.89, 337.2, 346, 356, 524.6, 710–719,
720– 724, 725–739, 729.1, 784, 805, 806, 846, 847.
Mental health conditions were classified using
Clinical Classifications Software ICD-9 codes from the
Agency for Healthcare Research and Quality (AHRQ)
[23]. We examined if patients had the following condi-
tions based on their frequent comorbidity with painful
conditions and HCV: anxiety disorders (i.e., anxiety dis-
order not otherwise specified [NOS], panic disorder, gen-
eralized anxiety disorder, agoraphobia with and without
panic, other anxiety states); major depressive disorder;
PTSD; and substance use disorder (combining alcohol
use disorder and drug use disorder).
Analysis
To compare sample characteristics by HCV diagnosis at
the bivariate level, we used v2 tests and t tests. To exam-
ine the association of covariates and primary variables of
interest with pain intensity, we used a series of logistic
regressions that modeled the probability of moderate/se-
vere pain intensity. Primary variables of interest included
current smoking status (current smoker vs former/never
smoker) and HCV diagnosis.
First, we examined unadjusted odds of reporting mod-
erate/severe pain by each variable. Second, a multivariate
logistic regression model was used to calculate the ad-
justed odds of moderate/severe pain with all variables of
interest. Finally, we tested an interaction term for
Smoking Status  HCV Diagnosis and all other variables
as above. Bivariate associations are reported as odds ra-
tios (ORs), multivariate associations as adjusted ORs
(AORs), and the results for the interaction test are
reported as a Wald v2 statistic. All statistical analyses
were performed using SAS, version 9.4 (SAS, Inc., Cary,
NC, USA).
Results
In this cohort of 654,841 OEF/OIF/OND veterans (me-
dian age [interquartile range]¼ 26 [23–36] years), we
identified 2,942 (0.4%) with an HCV diagnosis. More
than one-third of the sample (37.6%) was classified as
current smokers. Among all participants in the sample,
36.1% (N¼ 236,672) reported a maximum pain inten-
sity in the moderate to severe range. There were several
differences between veterans with and without HCV at
the bivariate level (Table 1). Compared with those with-
out HCV, veterans with HCV were more likely to be
white, older, male, and current smokers. Veterans with
HCV were also more likely to report moderate to severe
pain intensity and to have a pain diagnosis. Veterans
with HCV were more likely to be diagnosed with major
depressive disorder, anxiety disorder, PTSD, and sub-
stance use disorder.
In unadjusted analyses, all covariates and variables of
interest were significantly associated with higher odds of
reporting moderate to severe pain intensity (Table 2).
Compared with veterans without HCV, the unadjusted
odds of reporting moderate/severe pain were 1.82 times
higher (95% confidence interval [CI] ¼ 1.70–1.96) for
those with HCV. Compared with nonsmokers, the unad-
justed odds of reporting moderate/severe pain were 1.32
times higher (95% CI ¼ 1.30–1.33) for veterans who
smoked.
Results were similar after adjusting for other covari-
ates (Table 2). In adjusted analyses, all variables were sig-
nificantly associated with a higher odds of reporting
moderate/severe pain. Compared with veterans without
an HCV diagnosis, the adjusted odds of reporting
moderate/severe pain were 1.23 times higher (95% CI ¼
1.14–1.33) for those with HCV. In comparison with
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veterans who did not currently smoke, the adjusted odds
of reporting moderate/severe pain were 1.26 times higher
(95% CI ¼ 1.24–1.28) for smokers. There was a signifi-
cant Smoking Status  HCV Diagnosis interaction (Wald
v2 (1) ¼ 4.86, P ¼ 0.03). To probe the interaction, the
adjusted probability of reporting moderate/severe pain
was calculated by smoking status and HCV diagnosis.
Among veterans without HCV, smoking had a modest ef-
fect on the probability of reporting moderate/severe pain
(adjusted OR ¼ 1.26, P < 0.001). However, among vet-
erans with HCV, smoking had a significantly larger effect
on moderate/severe pain (adjusted OR ¼ 1.50, P <
0.001). Given unequal group prevalence of psychiatric
comorbidities by smoking status and HCV diagnosis, a
graph was created that shows the probability of moder-
ate/severe pain by smoking status and HCV diagnosis,
which also takes into account group differences in sub-
stance use, depression, and PTSD diagnoses (Figure 1).
After accounting for the prevalence of substance use,
depression, and PTSD among veterans with HCV, the ad-
justed probability of moderate/severe pain was 51.8%
(95% CI ¼ 0.494–0.543).
Discussion
This study used a national data set of veterans returning
from recent wars (OEF/OIF/OND) and demonstrated
that, compared with veterans without HCV, veterans
with HCV were more likely to report moderate/severe
pain intensity and to be current smokers. Although the
association between pain and smoking was significant
and positive for veterans with and without an HCV diag-
nosis, the association was significantly higher for patients
with an HCV diagnosis than those without. The associa-
tion between pain intensity and smoking status has been
previously reported, but, to our knowledge, this study is
the first to report this association in veterans with HCV.
Due to the high burden of chronic pain conditions in
Table 1. Sample Characteristics by HCV Diagnosis
HCV Diagnosis (N¼2,942) No HCV (N¼651,899) Total (N¼654,841) P value
Age, median (IQR), y 28 (23–43) 26 (23–36) 26 (23–36) <0.0001
Gender <0.0001
Women 9.8 12.7 12.7
Men 90.2 87.3 87.3
Race (missing 7,903), % <0.0001
White 68.1 64.5 64.5
Black 15.7 17.5 17.5
Hispanic 12.0 11.9 11.9
Other 4.2 6.1 6.1
Education (missing 171), % <0.0001
Less than high school 2.3 1.3 1.3
High school or higher 97.7 98.7 98.7
Marital status (missing 40,941), % <0.0001
Married 42.3 49.3 49.3
Not married 57.6 50.7 50.7
Rank, % <0.0001
Enlisted 97.1 93.3 93.3
Officer/warrant 2.9 6.7 6.7
Branch, % <0.0001
Army 71.9 61.3 61.3
Air Force 6.8 10.5 10.5
Marine Corps 9.1 14.6 14.6
Navy 12.2 13.6 13.6
At least 50% SC disability, % 60.7 41.8 42.9 <0.0001
Pain intensity, median (IQR) 4 (0–7) 1 (0–5) 1 (0–5) <0.0001
Pain intensity, % <0.0001
None to mild (0–3) 49.3 63.9 63.8
Moderate to severe (4–10) 50.7 36.1 36.1
Pain diagnoses, % 85.8 70.3 70.4 <0.0001
Mental health diagnoses, %
Major depression 28.9 11.1 11.2 <0.0001
PTSD 62.8 33.5 33.6 <0.0001
Anxiety 39.3 18.7 18.8 <0.0001
Substance use 57.3 15.0 12.8 <0.0001
Smoking status, % <0.0001
Current 58.2 37.5 37.6
Former 17.0 17.2 17.2
Never 24.8 45.3 45.2
HCV ¼ hepatitis C virus; IQR ¼ interquartile range; PTSD ¼ post-traumatic stress disorder; SC ¼ service-connected.
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patients with HCV, the study highlights the need to un-
derstand the impact of smoking status on pain intensity
and then develop interventions to promote smoking ces-
sation and pain management in this younger veteran
population.
In this study, patients with HCV had higher rates of
smoking compared with patients without HCV (58% vs
37%). Other studies have found even higher rates of
smoking among patients with HCV [6,7,11,24]. In a re-
cent survey of veterans with HCV, tobacco use was
found to be the most common substance use disorder,
with 66% of patients reporting a history of tobacco use
[14]. Unfortunately, there are numerous barriers to
smoking cessation for patients with HCV. In a qualitative
study of patients with HCV, almost a quarter (22.5%)
believed that smoking “helped fight the HCV” [25].
Patients with HCV would benefit from a smoking cessa-
tion program that highlights the negative consequences
of smoking (such as a pain condition) related to their
disease.
In this cohort of younger veterans, patients with HCV
had higher rates of moderate/severe pain intensity (51%
vs 36%) and pain conditions (86% vs 70%) compared
with veterans without HCV. In previous studies, more
than 80% of patients with HCV reported pain symptoms
[5] and over two-thirds (71%) of patients with HCV
reported joint pain [8]. Other studies have reported
higher rates of fibromyalgia [26], peripheral neuropathy
[27], and rheumatoid arthritis [28] among patients with
HCV. The mechanism for HCV increasing musculoskele-
tal conditions remains unclear but might include direct
invasion of the virus into the synovial tissue, an autoim-
mune response, and immune complex deposition [29].
More research is needed to understand whether treat-
ments for HCV improve these painful conditions.
In the multivariate model, mental health disorders
were associated with greater odds of reporting higher
pain intensity, which is consistent with previous litera-
ture illustrating the association between psychological
distress and pain [30,31]. Morasco et al. found that de-
pression severity was the most significant predictor of
both pain intensity and pain functioning in patients with
HCV [12]. Adams and colleagues found that patients
with HCV (43%) had clinically significant symptoms of
depression and 58% had chronic pain [32]. In a study ex-
amining quality of life in patients with HCV, both smok-
ing and alcohol use were associated with depression,
fatigue, difficulty sleeping, and loss of interest in sex [7].
Previous studies have found that patients with HCV re-
port using alcohol to cope with symptoms of PTSD and
depression [33]. Clinicians should be aware of the higher
rates of mental health disorders among patients with
HCV and incorporate treatment plans that support
mood, reduce distress, and promote pain coping accord-
ingly. Prior interventions among patients with HCV have
focused on cognitive behavioral self-management and ex-
ercise interventions to improve quality of life in areas
such as pain intensity, depression, mood, and vitality
[34,35].
This study has particular limitations. The cross-
sectional study design limits our capacity to determine a
temporal order of variables and to examine causation.
The study results may be specific to veteran populations
but less applicable to other clinical populations. We re-
lied on an algorithm to determine self-reported smoking
status, though we note that McGinnis et al. have vali-
dated this measure [21]. A single-item measure of pain in-
tensity does not account for the full dynamics of pain in
its quality, duration, and location [19]. Although prior
research has suggested using an average measure of pain
intensity because of short-term variability [36], we used
the highest pain intensity measure that was þ/- 30 days
from the most recent smoking status to select these varia-
bles close in time. Using ICD-9 coding in our study has
the potential to undercount comorbidities if providers
did not code them in the VHA EMR.
Figure 1. Probability of moderate to severe pain by smoking
status and hepatitis C virus diagnosis, taking into account
group differences in psychiatric comorbidity. Adjusted proba-
bility accounts for differences in group means in psychiatric di-
agnoses (depression, post-traumatic stress disorder, and
substance use disorders) and assumes omnibus group means
among all other covariates. HCV ¼ hepatitis C virus.
Table 2. Logistic Regression Models Predicting Moderate to
Severe Pain
Unadjusted Adjusted*
Variable OR† 95% CI OR† 95% CI
Age 1.01 1.01–1.01 1.01 1.01–1.01
Nonwhite (ref: white) 1.22 1.21–1.23 1.26 1.25–1.28
Male (ref: female) 1.05 1.03–1.07 1.01 0.99–1.02
Substance use disorder 1.74 1.72–1.77 1.17 1.15–1.19
Major depressive disorder 2.03 1.99–2.06 1.39 1.37–1.42
PTSD 2.35 2.33–2.38 2.11 2.09–2.14
Current smoker 1.32 1.30–1.33 1.26 1.25–1.28
Hepatitis C diagnosis 1.82 1.70–1.96 1.23 1.14–1.33
CI ¼ confidence interval; OR ¼ odds ratio; PTSD ¼ post-traumatic stress
disorder.
*Multivariate logistic model adjusted for all other variables.
†P < 0.001 for all modeled effects.
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Among veterans with HCV, this study illustrates the
association between smoking status and pain. Smoking
has a strong impact on the health of young veterans;
smoking cessation and prevention programs need to start
earlier in the military. As more patients with HCV un-
dergo curative therapy, clinicians will need to refocus
their attention on morbidities and mortalities associated
with other chronic conditions such as smoking. Persons
with HCV and chronic pain may be using smoking as a
way to cope with or reduce pain and may experience
more barriers to smoking cessation. Our research sug-
gests that it may be important to provide more patient
education about the links between smoking and pain, tar-
get smoking cessation, and provide assistance to manage
chronic pain for veterans with HCV. Future research
should examine the association of pain and smoking in
veterans who have undergone curative therapy for HCV.
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